Catalent
CTLT
#1737
Rank
HK$89.69 B
Marketcap
HK$494.17
Share price
0.00%
Change (1 day)
13.83%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : HK$38.51 Billion

According to Catalent's latest financial reports the company's total debt is HK$38.51 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30HK$38.08 B15.11%
2022-06-30HK$33.08 B30.82%
2021-06-30HK$25.28 B7.58%
2020-06-30HK$23.50 B1.69%
2019-06-30HK$23.11 B8.24%
2018-06-30HK$21.35 B31.55%
2017-06-30HK$16.23 B12.46%
2016-06-30HK$14.43 B-0.97%
2015-06-30HK$14.57 B-30.6%
2014-06-30HK$21.00 B0.63%
2013-06-30HK$20.87 B0.28%
2012-06-30HK$20.81 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Supernus Pharmaceuticals
SUPN
HK$0.32 B-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$2.62 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$42.25 B 9.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
HK$1.74 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA